ストックスクリーナーアプリを入手
3.10
11.51%
0.32
アフターアワーズ：
3.07
-0.03
-0.97%
前日終値:
$2.78
開ける：
$2.94
24時間の取引高:
115.48K
Relative Volume:
0.04
時価総額：
$8.85M
収益：
-
当期純損益:
$-7.97M
株価収益率:
-0.7964
EPS:
-3.8923
ネットキャッシュフロー:
$-6.79M
1週間 パフォーマンス:
+4.73%
1か月 パフォーマンス:
-20.10%
6か月 パフォーマンス:
-56.52%
1年 パフォーマンス:
-59.21%
1日の値動き範囲:
$2.90
$3.18
1週間の範囲:
$2.43
$3.18
52週間の値動き範囲:
$1.3259
$21.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
名前
Acurx Pharmaceuticals Inc
セクター
電話
917-533-1469
住所
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
3.10 | 7.94M | 0 | -7.97M | -6.79M | -3.8923 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Acurx Pharmaceuticals Inc (ACXP) 最新ニュース
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Market Leaders: What analysts say about Acurx Pharmaceuticals Inc stock2026 Outlook & Daily Profit Focused Stock Screening - baoquankhu1.vn
New to The Street Broadcasts on Bloomberg TV, Featuring IGC, VVOS, ACXP, and EQX - National Today
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Idaho Statesman
ACXP Stock Price, Quote & Chart | ACURX PHARMACEUTICALS INC (NASDAQ:ACXP) - ChartMill
Is Acurx Pharmaceuticals (ACXP) stock outpacing its medical peers this year? - MSN
Risk Check: Can Acurx Pharmaceuticals Inc disrupt its industryQuarterly Trade Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor Events - ACCESS Newswire
Profit Recap: What is Acurx Pharmaceuticals Incs 5 year growth outlook2026 Winners & Losers & Fast Moving Trade Plans - baoquankhu1.vn
CEO Change: What are the risks of holding Acurx Pharmaceuticals IncEarnings Summary Report & Long-Term Growth Portfolio Plans - baoquankhu1.vn
ACXP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings (VTIX), HPB, Jonas & Redman, Acurx Pharmaceuticals (ACXP), and FreeCast (CAST) - ACCESS Newswire
Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year? - finance.yahoo.com
ACXP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is the dividend yield of Acurx Pharmaceuticals IncMarket Growth Report & Daily Stock Momentum Reports - baoquankhu1.vn
Acurx Pharmaceuticals Secures Korean Patent To Strengthen DNA Polymerase IIIC Inhibitor Portfolio - BioPharma APAC
Earnings Report: Is Acurx Pharmaceuticals Inc stock undervalued right now2026 Trading Volume Trends & Reliable Price Breakout Signals - baoquankhu1.vn
South Korea grants Acurx patent as it pushes new infection drugs - Stock Titan
Day Trade: Can Acurx Pharmaceuticals Inc disrupt its industryProduct Launch & Low Drawdown Trading Strategies - baoquankhu1.vn
Acurx Pharmaceuticals, Inc.Common Stock (Nasdaq:ACXP) Stock Quote - FinancialContent
Can Acurx Pharmaceuticals (ACXP) climb 226.3% to reach the level Wall Street analysts expect? - msn.com
ACXP Forecast, Price Target & Analyst Ratings | ACURX PHARMACEUTICALS INC (NASDAQ:ACXP) - ChartMill
Acurx Pharmaceuticals Inc (ACXP) Q4 2025 Earnings Call Highlights: Financial Growth and ... By GuruFocus - Investing.com Canada
What's going on with Acurx Pharmaceuticals stock today? - MSN
Why is Acurx Pharmaceuticals stock falling Thursday? - MSN
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect? - sharewise.com
Can Acurx Pharmaceuticals (ACXP) Surge by 226.3% to Meet the Target Set by Wall Street Analysts? - Bitget
Can Acurx Pharmaceuticals (ACXP) Rise by 226.3% to Meet the Target Set by Wall Street Experts? - Bitget
Acurx signals launch of pivotal recurrent CDI trial in H2 2026 while strengthening ibezapolstat pipeline - MSN
Is Acurx Pharmaceuticals (ACXP) outperforming other medical stocks this year? - MSN
Acurx Pharmaceuticals Drives Stock Surge with Major Clinical Developments - StocksToTrade
Is Acurx Pharmaceuticals (ACXP) Surpassing Other Healthcare Stocks in Performance This Year? - Bitget
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP) - The Globe and Mail
What's Going On With Acurx Pharmaceuticals Stock Today? - Sahm
Acurx Pharmaceuticals (ACXP) Gets a Buy from Alliance Global Partners - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), BioLife Solutions (BLFS) - The Globe and Mail
Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch - Investing.com Canada
Acurx Pharmaceuticals (ACXP) Stock Rockets 218% as Phase 3 CDI Trial Gets Green Light - MEXC
Acurx Pharmaceuticals Inc (ACXP) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):